Novo Nordisk sees pills capturing over third of GLP-1 market by 2030 | REUTERS

Oral weight-loss drugs could account for a third or more of the overall GLP-1 market by 2030, a Novo Nordisk executive said, a larger percentage than the company originally anticipated. #News #Reuters #Newsfeed #weightloss #weightlossdrugs #novonordisk #glp1medications Read the story here: https://reut.rs/4jDacvC 👉 Subscribe: http://smarturl.it/reuterssubscribe Keep up with the latest news from around the world: https://www.reuters.com/ Follow Reuters on Facebook: https://www.facebook.com/Reuters Follow Reuters on Twitter: https://twitter.com/Reuters Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en